Generated $48.1 million in XDEMVY® net product sales driven by more than 41,400 bottles delivered to patients in the third quarterStrengthened ...

Other ocular adverse reactions reported by less than 2% of patients were chalazion/hordeolum (stye) and punctate keratitis. XDEMVY is indicated for the treatment of Demodex blepharitis.

Other side effects in less than 2% of patients were chalazion/hordeolum and punctate keratitis. About TP-04TP-04 is an aqueous gel formulation of lotilaner, a well-characterized anti-parasitic ...

Other ocular adverse reactions reported by less than 2% of patients were chalazion/hordeolum (stye) and punctate keratitis. Most common side effects: The most common side effect in clinical trials was ...

Join MIMS now and pay nothing for the first 30 days Join GPOnline now and pay nothing for the first 30 days ...

IRVINE, Calif., Nov. 13, 2024 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), whose mission is to focus on unmet needs and apply proven science and new technology to revolutionize ...

An ingrown eyelash (trichiasis) is a common eye problem that causes eyelashes to grow abnormally. Instead of growing out, ingrown eyelashes grow inward toward the eye. Since eyelashes are usually very ...